Kyntra Bio (KYNB) Gross Profit (2018 - 2026)
Kyntra Bio (KYNB) posted Gross Profit of -$368000.0 for Q1 2026, down 136.84% sequentially from $999000.0 in Q4 2025, and down 114.8% YoY from $2.5 million in Q1 2025.
Kyntra Bio (KYNB) Gross Profit (2018 - 2026) Analysis & Trends
Kyntra Bio has reported Gross Profit for 9 years, with the latest figure at -$368000.0 in Q1 2026.
- Quarterly Gross Profit fell 114.8% year-over-year to -$368000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 75.27% YoY) and the FY2025 annual result came in at $5.9 million, down 58.15% from the prior year.
- Gross Profit retreated to -$368000.0 in Q1 2026 per KYNB's latest filing, from $999000.0 in the prior quarter.
- Over five years, Gross Profit peaked at $35.9 million in Q3 2023 and troughed at -$64.3 million in Q4 2023.
- A 5-year average of $1.0 million and a median of $1.3 million in 2025 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2023 and 2025: Gross Profit plunged 1951.28% in 2023, then jumped 2020.83% in 2025.
- Over 5 years, Gross Profit stood at $3.5 million in 2022, then slumped by 1951.28% to -$64.3 million in 2023, then jumped by 113.96% to $9.0 million in 2024, then sank by 88.88% to $999000.0 in 2025, then tumbled by 136.84% to -$368000.0 in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered -$368000.0, $999000.0, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Mn |
| Jun 30, 2026 | 1.47 Mn |
| Mar 31, 2026 | -368,000.00 |
| Mar 31, 2026 | -368,000.00 |
| Dec 31, 2025 | 999,000.00 |
| Dec 31, 2025 | 999,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 8.98 Mn |
| Dec 31, 2024 | 8.98 Mn |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 260,000.00 |
| Jun 30, 2024 | 260,000.00 |
| Mar 31, 2024 | -18.90 Mn |
| Mar 31, 2024 | -18.90 Mn |